1,261 followers
RT @TargetOncology: Our latest @AdisJournals Drug Evaluation on #Niraparib in #OvarianCancer https://t.co/FF2fEpFlWM #PARP
RT @TargetOncology: Our latest @AdisJournals Drug Evaluation on #Niraparib in #OvarianCancer https://t.co/FF2fEpFlWM #PARP
Our latest @AdisJournals Drug Evaluation on #Niraparib in #OvarianCancer https://t.co/FF2fEpFlWM #PARP
Niraparib: A Review in Ovarian Cancer. https://t.co/y02QocXUHz